Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
HR795119th CongressWALLET
Pregnancy Is Not an Illness Act of 2025
Sponsored By: Representative Miller, Mary E. [R-IL-15]
Introduced
Summary
Would bar the FDA from treating pregnancy as an illness when approving abortion drugs. It would also void any approval that relied on that treatment and specifically nullify the FDA approval of mifepristone in effect before enactment.
Show full summary
- Families and patients: Could lose FDA-approved access to mifepristone and any other abortion drug whose approval relied on treating pregnancy as an illness.
- Healthcare providers: Would no longer have affected FDA approvals to rely on when prescribing or dispensing those abortion drugs.
- Drug manufacturers and regulators: Approvals that used pregnancy-as-illness rationale would be invalidated, and the Department of Health and Human Services, including the FDA, would be barred from using that rationale to approve drugs or impose risk evaluation and mitigation strategies.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Cancel FDA abortion drug approvals
If enacted, the bill would bar HHS and the Food and Drug Administration from treating pregnancy as an illness. That bar would apply to approving abortion drugs and to REMS safety rules. It would cancel any FDA approval that relied in whole or in part on treating pregnancy as an illness. The cancellation would explicitly include the mifepristone approval in effect the day before enactment. If passed, manufacturers, pharmacies, prescribers, and patients could lose legal permission to make, sell, or use these medicines. This could reduce access and raise costs for people who use or prescribe medication abortion.
Sponsors & CoSponsors
Sponsor
Miller, Mary E. [R-IL-15]
IL • R
Cosponsors
Rep. Babin, Brian [R-TX-36]
TX • R
Sponsored 1/28/2025
Rep. Moore, Riley M. [R-WV-2]
WV • R
Sponsored 1/28/2025
Rep. Ogles, Andrew [R-TN-5]
TN • R
Sponsored 1/28/2025
Rep. Webster, Daniel [R-FL-11]
FL • R
Sponsored 1/28/2025
Rep. Tenney, Claudia [R-NY-24]
NY • R
Sponsored 1/28/2025
Rep. Harris, Andy [R-MD-1]
MD • R
Sponsored 1/28/2025
Rep. Weber, Randy K. Sr. [R-TX-14]
TX • R
Sponsored 1/28/2025
Rep. Harris, Mark [R-NC-8]
NC • R
Sponsored 2/4/2025
Green (TN)
TN • R
Sponsored 3/18/2025
Brecheen
OK • R
Sponsored 5/7/2025
Rep. McGuire, John J. [R-VA-5]
VA • R
Sponsored 5/8/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov